RNAC icon

Cartesian Therapeutics
RNAC

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $105M invested in Cartesian Therapeutics in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$26.9M
2
+$25.8M
3
+$6.3M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$4.21M
5
UBS Group
UBS Group
Switzerland
+$4.15M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$26.9M
2
$25.8M
3
$23.1M
4
$6.3M
5
$4.21M
6
$4.15M
7
$4M
8
$2.5M
9
$2.45M
10
$1.68M
11
$1.06M
12
$656K
13
$506K
14
$358K
15
$350K
16
$350K
17
$350K